Perspectives on Tuberculosis Pathogenesis and Discovery of Anti-Tubercular Drugs

被引:7
作者
Ntie-Kang, Fidele [1 ,2 ,3 ]
Yong, Joseph N. [4 ]
Owono, Luc C. Owono [1 ,5 ]
Sippl, Wolfgang [3 ]
Megnassan, Eugene [6 ]
机构
[1] Univ Douala, Fac Sci, CEPAMOQ, Douala, Cameroon
[2] Univ Buea, Fac Sci, Dept Chem, Chem & Bioact Informat Ctr, Buea, Cameroon
[3] Univ Halle Wittenberg, Dept Pharmaceut Sci, D-06120 Halle, Saale, Germany
[4] Univ Buea, Fac Sci, Dept Chem, Buea, Cameroon
[5] Univ Yaounde I, Ecole Normale Super, Lab Simulat & Biomol Phys, Yaounde, Cameroon
[6] Univ Abobo Adjame, Lab Fundamental & Appl Phys, Abidjan, Cote Ivoire
关键词
Drug discovery; drug resistance; in silico screening; tuberculosis; HIGH-THROUGHPUT DOCKING; MYCOBACTERIUM-TUBERCULOSIS; NATURAL-PRODUCTS; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY; COMBINATORIAL CHEMISTRY; ASPARTIC PROTEASE; POTENT INHIBITORS; THYMIDINE ANALOGS; MEDICINAL-PLANTS;
D O I
10.2174/0929867321666140706144933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on the global burden of tuberculosis and resistant strains that have recently emerged, not responding to existing therapies, it has become urgent to search for new remedies against this global human plague that has been compounded by HIV co-infection. Thus, the search for new drugs against the disease-causing agent, Mycobacterium tuberculosis (MTB), is an ongoing effort. This review discusses the state-of-the-art in anti-tuberculosis pathogenesis and anti-TB drug research, identifying some of the challenges being faced by researchers in the field and sheds light on possible ways forward, particularly in low-income countries.
引用
收藏
页码:3466 / 3477
页数:12
相关论文
共 153 条
[1]   High-throughput docking for lead generation [J].
Abagyan, R ;
Totrov, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) :375-382
[2]   Natural product-like combinatorial libraries [J].
Abreu, PM ;
Branco, PS .
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2003, 14 (05) :675-712
[3]   Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv [J].
Agrawal, Himanshu ;
Kumar, Ashutosh ;
Bal, Naresh Chandra ;
Siddiqi, Mohammad Imran ;
Arora, Ashish .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) :3053-3058
[4]  
Aitken S. G., 2006, CHEM NZ, P88
[5]   Rational Design and 3D-Pharmacophore Mapping of 5′-Thiourea-Substituted α-Thymidine Analogues as Mycobacterial TMPK Inhibitors [J].
Andrade, Carolina H. ;
Pasqualoto, Kerly F. M. ;
Ferreira, Elizabeth I. ;
Hopfinger, Anton J. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (04) :1070-1078
[6]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[7]   Bigger isn't always better [J].
不详 .
NATURE, 2002, 418 (6896) :353-353
[8]  
[Anonymous], 2008, TUBERCULOSIS, V88, P85
[9]  
[Anonymous], 2008, Global tuberculosis control - surveillance, planning, financing
[10]  
[Anonymous], 2009, GLOB TUB CONTR SHORT